Evolent Health, Inc. (EVH)

Market Cap	445.43M -61.6%
Revenue (ttm)	1.89B -21.3%
Net Income	-533.78M
EPS	-4.71
Shares Out	112.48M
PE Ratio	n/a
Forward PE	15.43
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,847,129
Open	4.070
Previous Close	4.100
Day's Range	3.840 - 4.230
52-Week Range	2.095 - 12.065
Beta	0.84
Analysts	Buy
Price Target	5.75 (+85.61%)
Earnings Date	May 7, 2026

About EVH

Evolent Health, Inc., through its subsidiary, provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated value-based care platform for health plan administration and management. It also provides administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, an...

• Industry: Health Information Services
• Sector: Healthcare
• IPO Date: Jun 5, 2015
• Employees: 4,200
• Stock Exchange: NYSE
• Ticker Symbol: EVH
• Website: https://www.evolent.com

Financial Performance

In 2025, Evolent Health's revenue was $1.88 billion, a decrease of -26.56% compared to the previous year's $2.55 billion. Losses were -$579.40 million, 520.0% more than in 2024.

Analyst Summary

According to 16 analysts, the average rating for EVH stock is "Buy." The 12-month stock price target is $5.75, which is an increase of 85.61% from the latest price.

Price Target

$5.75

(85.61% upside)

Analyst Consensus: Buy